tirzepatide weight loss trial versus Semaglutide Once Weekly in Patients with Type 2 Diabetes Tirzepatide for the Maintenance of
Description
Zepbound is the FDA-approved tirzepatide registered for weight management, and certain individuals may qualify for an online prescription
Not intended for human consumption, therapeutic use, veterinary application, or medical treatment.
A prescriber may increase the dose in increments of up to 15 milligrams once weekly, following the labeled titration schedule
Protocols do not run forever
Patients begin with a lower dose and works their way up through the treatment, until they hit the maintenance dose of 2.4 mg, as long as they can tolerate it
Many individuals notice they feel satisfied with smaller portions, which naturally lowers overall calorie intake
